Terry O’Flynn’s Four T’s of Philanthropy
Time
Time is one of the most valuable gifts a philanthropist can give. Terry has dedicated countless hours to supporting numerous organizations throughout the Edmonton region. Here are a few comments from longtime friends and business colleagues, Dennis Mozak, Barry Robertson and Dr. Bob Steadward, reflecting on Terry’s commitment to causes that matter.
TALENT
Talent isn’t just about what you do – it’s about how you use your skills to help others. Terry has shared his unique expertise to help charities throughout the Edmonton region thrive. Hear from Craig Simpson on how Terry uses his talents to make an impact
TREASURE
True philanthropy isn’t just about giving – it’s about inspiring others to give as well. Here, Patrick Laforge shares an example of how Terry was able to rally others to support a cause.
TIES
Philanthropy isn’t just about individual giving – it’s about the connections we build and the impact we create through those relationships. Here are Len Rhodes and Kate Gallagher commenting on the strength of Terry’s ties within the community.
Bonus
TESTIMONY
Terry’s legacy is about more than just the work he’s done – it’s about the people he’s brought together and the lasting impact he’s had on them. Over the years, Terry has reached countless corners of the community, building relationships across businesses and organizations. His mentorship has been a guiding force for many, and his approach to philanthropy is always thoughtful and strategic. Kate Gallagher reflects on how Terry’s leadership and generosity have shaped not only the community, but also the lives of those who’ve had the privilege of working alongside him.
Contribute to Terry's Philanthropy Through
the Toast of the Town
Your donation will help fund:
- 4 CliniMACS Prodigy units to manufacture CAR T-cells for treatment and research
- MACSQuant Analyzer for quality control and analysis of the modified cells
- QuantStudio 12K Flex for working with DNA and building cell therapies
- xCELLigence eSight Platform to test multiple treatment prototypes simultaneously, speeding up research and saving lives
